HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 89 filers reported holding HARVARD BIOSCIENCE INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $211,000 | +61.1% | 33,916 | +83.2% | 0.00% | – |
| Q4 2021 | $131,000 | -29.2% | 18,516 | -30.0% | 0.00% | – |
| Q3 2021 | $185,000 | -86.3% | 26,465 | -83.7% | 0.00% | -100.0% |
| Q2 2021 | $1,351,000 | +1610.1% | 162,134 | +1019.8% | 0.00% | – |
| Q1 2021 | $79,000 | +16.2% | 14,479 | -8.4% | 0.00% | – |
| Q4 2020 | $68,000 | +23.6% | 15,811 | +23.5% | 0.00% | – |
| Q1 2019 | $55,000 | -11.3% | 12,801 | -21.8% | 0.00% | – |
| Q3 2015 | $62,000 | -68.4% | 16,364 | -65.9% | 0.00% | – |
| Q3 2014 | $196,000 | -10.5% | 47,988 | -0.1% | 0.00% | – |
| Q2 2014 | $219,000 | -4.8% | 48,060 | -1.0% | 0.00% | -100.0% |
| Q1 2014 | $230,000 | -2.5% | 48,549 | -3.5% | 0.00% | 0.0% |
| Q4 2013 | $236,000 | +105.2% | 50,317 | +130.5% | 0.00% | – |
| Q3 2013 | $115,000 | +66.7% | 21,833 | +48.9% | 0.00% | – |
| Q2 2013 | $69,000 | – | 14,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 3,542,852 | $10,536,000 | 4.92% |
| Fondren Management LP | 865,000 | $2,660,000 | 2.21% |
| Harvey Partners, LLC | 742,500 | $2,283,000 | 1.65% |
| BARD ASSOCIATES INC | 311,922 | $959,000 | 0.49% |
| Adirondack Research & Management Inc. | 131,042 | $403,000 | 0.35% |
| Granahan Investment Management | 1,771,964 | $5,449,000 | 0.30% |
| DALTON GREINER HARTMAN MAHER & CO | 1,373,518 | $4,224,000 | 0.29% |
| HEARTLAND ADVISORS INC | 1,000,000 | $3,075,000 | 0.24% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 499,616 | $1,536,000 | 0.22% |
| Alambic Investment Management, L.P. | 43,569 | $134,000 | 0.10% |